12,813 Shares in Lam Research Corporation $LRCX Purchased by Impax Asset Management Group plc

Impax Asset Management Group plc purchased a new stake in shares of Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 12,813 shares of the semiconductor company’s stock, valued at approximately $1,247,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its stake in shares of Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares during the last quarter. Mutual of America Capital Management LLC purchased a new position in Lam Research during the 1st quarter valued at $13,345,000. Stephens Inc. AR grew its position in Lam Research by 55.0% in the 1st quarter. Stephens Inc. AR now owns 9,603 shares of the semiconductor company’s stock valued at $698,000 after acquiring an additional 3,409 shares during the last quarter. CWM LLC increased its stake in Lam Research by 32.0% in the first quarter. CWM LLC now owns 66,123 shares of the semiconductor company’s stock worth $4,807,000 after purchasing an additional 16,028 shares during the period. Finally, Edgestream Partners L.P. increased its stake in Lam Research by 29.0% in the first quarter. Edgestream Partners L.P. now owns 4,168 shares of the semiconductor company’s stock worth $303,000 after purchasing an additional 938 shares during the period. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 62,528 shares of company stock worth $8,880,448. 0.31% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

LRCX has been the subject of a number of recent analyst reports. UBS Group set a $165.00 target price on shares of Lam Research and gave the company a “buy” rating in a research note on Thursday, October 23rd. Weiss Ratings reiterated a “buy (b-)” rating on shares of Lam Research in a report on Wednesday, November 5th. Berenberg Bank upped their target price on shares of Lam Research from $122.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. JPMorgan Chase & Co. raised their target price on shares of Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, October 23rd. Finally, Barclays set a $142.00 price target on shares of Lam Research and gave the company an “equal weight” rating in a research note on Monday, October 20th. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $149.04.

Lam Research Trading Down 5.0%

NASDAQ:LRCX opened at $153.32 on Friday. The firm has a 50-day simple moving average of $139.84 and a 200-day simple moving average of $108.87. Lam Research Corporation has a one year low of $56.32 and a one year high of $167.15. The firm has a market cap of $192.57 billion, a P/E ratio of 33.77, a P/E/G ratio of 1.68 and a beta of 1.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s quarterly revenue was up 27.7% on a year-over-year basis. During the same period last year, the firm earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.